dc.creatorSambra Vásquez, Verónica Marcela
dc.creatorEcheverría González, Francisca Cecilia
dc.creatorValenzuela, Alfonso
dc.creatorChouinard Watkins, Raphaël
dc.creatorValenzuela Báez, Rodrigo Wladimir
dc.date.accessioned2021-11-03T22:16:41Z
dc.date.accessioned2022-01-27T22:15:14Z
dc.date.available2021-11-03T22:16:41Z
dc.date.available2022-01-27T22:15:14Z
dc.date.created2021-11-03T22:16:41Z
dc.date.issued2021
dc.identifierNutrients 2021, 13, 986
dc.identifier10.3390/nu13030986
dc.identifierhttps://repositorio.uchile.cl/handle/2250/182567
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3318004
dc.description.abstractThe role of docosahexaenoic acid (DHA) and arachidonic acid (AA) in neurogenesis and brain development throughout the life cycle is fundamental. DHA and AA are long-chain polyunsaturated fatty acids (LCPUFA) vital for many human physiological processes, such as signaling pathways, gene expression, structure and function of membranes, among others. DHA and AA are deposited into the lipids of cell membranes that form the gray matter representing approximately 25% of the total content of brain fatty acids. Both fatty acids have effects on neuronal growth and differentiation through the modulation of the physical properties of neuronal membranes, signal transduction associated with G proteins, and gene expression. DHA and AA have a relevant role in neuroprotection against neurodegenerative pathologies such as Alzheimer’s disease and Parkinson’s disease, which are associated with characteristic pathological expressions as mitochondrial dysfunction, neuroinflammation, and oxidative stress. The present review analyzes the neuroprotective role of DHA and AA in the extreme stages of life, emphasizing the importance of these LCPUFA during the first year of life and in the developing/prevention of neurodegenerative diseases associated with aging.
dc.languageen
dc.publisherMDPI
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.sourceNutrients
dc.subjectDocosahexaenoic acid
dc.subjectArachidonic acid
dc.subjectNeuroprotection
dc.subjectNeurodegeneration
dc.subjectAlzheimer’s disease
dc.subjectParkinson’s disease
dc.titleDocosahexaenoic and arachidonic acids as neuroprotective nutrients throughout the life cycle
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución